Early‑phase drug development doesn’t have to be slow, siloed or risky. In this short, insight‑packed conversation, **Paul Fleming — Technical Director at Medicines UK and former MHRA regulator — joins Calum Stevens at BDD Pharma’s BioCity Glasgow facility to explain how Lean Clinical Development™ is cutting timelines without compromising quality.

Together they explore:

• Paul’s journey from regulation to industry leadership
• The integration of formulation, gamma scintigraphy and PK studies into one seamless package
• Why the NHS and progressive UK regulation make Britain an ideal home for first‑in‑human trials
• Practical advice for innovators choosing the right CDMO partner

Watch the video for the complete discussion.